• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解治疗指南的依从性:斯卡拉堡初级保健数据库中他汀类药物处方的多水平分析。

Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database.

机构信息

R&D Centre, Skaraborg Primary Care, Skövde, Sweden.

Social Epidemiology, Department of Clinical Science, Faculty of Medicine, Lund University, Malmö, Sweden.

出版信息

Eur J Clin Pharmacol. 2011 Apr;67(4):415-423. doi: 10.1007/s00228-010-0973-4. Epub 2010 Dec 29.

DOI:10.1007/s00228-010-0973-4
PMID:21190018
Abstract

PURPOSE

In Skaraborg, Sweden, the economic responsibility for tax-financed prescription drug costs was transferred from the regional administrative level to the local level (health care centre; HCC) in 2003. The aim of this study was to investigate the impact of this decentralization of economic responsibility on adherence to guidelines for prescribing lipid-lowering drugs.

METHODS

Data from all 24 public HCCs in Skaraborg on prescriptions for lipid-lowering drugs during 2003 and 2005 were extracted from the Skaraborg Primary Care Database (SPCD). Multilevel regression analysis (MLRA) was used to disentangle the variances at different levels of data (patient, physician, HCC). The outcome variable on the patient level was the prescription of the recommended statin (yes/no). Sex and age of the patients and sex, age and occupational status of the physician were included as fixed effects. The variance was expressed as the median odds ratio (MOR).

RESULTS

The prevalence of adherence to guidelines for the prescription of statins increased from 77% in 2003 to 84% in 2005. The MLRA showed that in 2003 the variance was equally distributed between the HCC and physician levels (MOR(HCC2003)=1.89 vs. MOR(PHYSICIAN2003)=1.88). The variance between physicians and between HCCs decreased considerably between 2003 and 2005. The inclusion of individual and physician characteristics did not explain any of the remaining variance.

CONCLUSION

The decentralized budget appears to have increased adherence to guidelines and reduced inefficient variation in prescribing.

摘要

目的

在瑞典的斯科讷省,2003 年将税收资助的处方药费用的经济责任从地区行政级别转移到地方级别(医疗保健中心;HCC)。本研究旨在调查这种经济责任分散化对遵循降脂药物处方指南的影响。

方法

从斯科讷初级保健数据库(SPCD)中提取了 2003 年和 2005 年斯科讷省所有 24 个公共 HCC 开具的降脂药物处方数据。采用多水平回归分析(MLRA)来分解数据(患者、医生、HCC)不同层面的方差。患者层面的结果变量是开具推荐的他汀类药物(是/否)。患者的性别和年龄以及医生的性别、年龄和职业状况被纳入固定效应。方差表示为中位数优势比(MOR)。

结果

2003 年至 2005 年,遵循他汀类药物处方指南的比例从 77%增加到 84%。MLRA 显示,2003 年 HCC 和医生层面的方差分布相当(MOR(HCC2003)=1.89 与 MOR(PHYSICIAN2003)=1.88)。医生之间和 HCC 之间的方差在 2003 年至 2005 年间显著降低。纳入个体和医生特征并不能解释任何剩余的方差。

结论

分散的预算似乎增加了对指南的遵循,并减少了处方的低效变化。

相似文献

1
Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database.理解治疗指南的依从性:斯卡拉堡初级保健数据库中他汀类药物处方的多水平分析。
Eur J Clin Pharmacol. 2011 Apr;67(4):415-423. doi: 10.1007/s00228-010-0973-4. Epub 2010 Dec 29.
2
Understanding adherence to official guidelines on statin prescribing in primary health care--a multi-level methodological approach.了解初级卫生保健中他汀类药物处方遵循官方指南的情况——一种多层次的方法。
Eur J Clin Pharmacol. 2005 Oct;61(9):657-65. doi: 10.1007/s00228-005-0975-9. Epub 2005 Oct 19.
3
Understanding the effects of a decentralized budget on physicians' compliance with guidelines for statin prescription--a multilevel methodological approach.理解分散预算对医生遵循他汀类药物处方指南的影响——一种多层次方法学途径。
BMC Health Serv Res. 2007 May 8;7:68. doi: 10.1186/1472-6963-7-68.
4
Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden.医生对处方指南的遵循是医疗实践的普遍特征还是取决于药物类型?——瑞典南部的一项多层次逻辑回归分析
Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):682-90. doi: 10.1002/pds.1767.
5
[Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial].[2013年多间隙试验中的降脂治疗与患者依从性]
Orv Hetil. 2014 Apr 27;155(17):669-75. doi: 10.1556/OH.2014.29905.
6
Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study.挪威他汀类药物高、中、低消费县的他汀类药物处方情况——一项基于个体水平处方数据库的研究
BMC Clin Pharmacol. 2007 Dec 5;7:14. doi: 10.1186/1472-6904-7-14.
7
Variation in plasma calcium analysis in primary care in Sweden--a multilevel analysis.瑞典初级保健中血浆钙分析的变化——一项多层次分析。
BMC Fam Pract. 2010 May 30;11:43. doi: 10.1186/1471-2296-11-43.
8
Pharmacoeconomic impact evaluation of statin adherence in high-risk unselected post myocardial infarction population: an administrative database-guided analysis.高危未筛选心肌梗死后人群中他汀类药物依从性的药物经济学影响评估:一项行政数据库引导的分析
Med Arch. 2013;67(5):314-7. doi: 10.5455/medarh.2013.67.314-317.
9
Effect of an Automated Patient Dashboard Using Active Choice and Peer Comparison Performance Feedback to Physicians on Statin Prescribing: The PRESCRIBE Cluster Randomized Clinical Trial.使用主动选择和同行比较绩效反馈的患者自动仪表板对医生开具他汀类药物的影响:PRESCRIBE 集群随机临床试验。
JAMA Netw Open. 2018 Jul 6;1(3):e180818. doi: 10.1001/jamanetworkopen.2018.0818.
10
Physician variation in the de-adoption of ineffective statin and fibrate therapy.医生在停用无效的他汀类药物和贝特类药物治疗方面的差异。
Health Serv Res. 2021 Oct;56(5):919-931. doi: 10.1111/1475-6773.13630. Epub 2021 Feb 10.

引用本文的文献

1
Identifying factors explaining practice variation in secondary stroke prevention in primary care: a cohort study based on all patients with ischaemic stroke in the Stockholm region.确定初级保健中二级预防卒中实践差异的因素:基于斯德哥尔摩地区所有缺血性卒中患者的队列研究。
BMJ Open. 2022 Nov 21;12(11):e064277. doi: 10.1136/bmjopen-2022-064277.
2
Cross-classified Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA) to evaluate hospital performance: the case of hospital differences in patient survival after acute myocardial infarction.交叉分类多水平分析个体异质性和判别准确性(MAIHDA)评估医院绩效:以急性心肌梗死后患者生存率的医院差异为例。
BMJ Open. 2020 Oct 23;10(10):e036130. doi: 10.1136/bmjopen-2019-036130.
3

本文引用的文献

1
Validity of registration of ICD codes and prescriptions in a research database in Swedish primary care: a cross-sectional study in Skaraborg primary care database.在瑞典初级保健中研究数据库中 ICD 代码和处方的注册有效性:在 Skaraborg 初级保健数据库中的一项横断面研究。
BMC Med Inform Decis Mak. 2010 Apr 23;10:23. doi: 10.1186/1472-6947-10-23.
2
Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden.医生对处方指南的遵循是医疗实践的普遍特征还是取决于药物类型?——瑞典南部的一项多层次逻辑回归分析
Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):682-90. doi: 10.1002/pds.1767.
3
Geographical and sociodemographic differences in discontinuation of medication for Chronic Obstructive Pulmonary Disease - A Cross-Classified Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA).慢性阻塞性肺疾病药物治疗中断的地理和社会人口学差异——个体异质性与判别准确性的交叉分类多水平分析(MAIHDA)
Clin Epidemiol. 2020 Jul 20;12:783-796. doi: 10.2147/CLEP.S247368. eCollection 2020.
4
Disentangling the contribution of hospitals and municipalities for understanding patient level differences in one-year mortality risk after hip-fracture: A cross-classified multilevel analysis in Sweden.解析医院和市政当局对理解髋部骨折后一年内死亡率风险的患者水平差异的贡献:瑞典的交叉分类多水平分析。
PLoS One. 2020 Jun 3;15(6):e0234041. doi: 10.1371/journal.pone.0234041. eCollection 2020.
5
Trends and Geographical Variability in Osteoporosis Treatment After Hip Fracture: A Multilevel Analysis of 30,965 Patients in the Region of Valencia, Spain.髋部骨折后骨质疏松症治疗的趋势及地理差异:对西班牙巴伦西亚地区30965名患者的多水平分析
J Bone Miner Res. 2020 Sep;35(9):1660-1667. doi: 10.1002/jbmr.4028. Epub 2020 May 5.
6
Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.分享 35 之后,死者供肝肝移植率的地域差异。
Transplantation. 2019 Oct;103(10):2113-2120. doi: 10.1097/TP.0000000000002643.
7
Albuminuria measurement in diabetic care: a multilevel analysis measuring the influence of accreditation on institutional performance.糖尿病护理中的白蛋白尿测量:一项测量认证对机构绩效影响的多层次分析。
BMJ Open Qual. 2019 Jan 14;8(1):e000449. doi: 10.1136/bmjoq-2018-000449. eCollection 2019.
8
The median hazard ratio: a useful measure of variance and general contextual effects in multilevel survival analysis.中位数风险比:多级生存分析中方差和一般背景效应的有用度量。
Stat Med. 2017 Mar 15;36(6):928-938. doi: 10.1002/sim.7188. Epub 2016 Nov 25.
9
Bad apples or spoiled barrels? Multilevel modelling analysis of variation in high-risk prescribing in Scotland between general practitioners and between the practices they work in.坏苹果还是变质桶?对苏格兰全科医生及其工作的诊所之间高风险处方差异的多层次建模分析。
BMJ Open. 2015 Nov 6;5(11):e008270. doi: 10.1136/bmjopen-2015-008270.
10
Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases.在基层医疗中,糖尿病合并高心血管风险患者使用贝特类药物单药治疗:一项基于国家行政数据库的法国全国队列研究。
PLoS One. 2015 Sep 23;10(9):e0137733. doi: 10.1371/journal.pone.0137733. eCollection 2015.
Therapeutic traditions, patient socioeconomic characteristics and physicians' early new drug prescribing--a multilevel analysis of rosuvastatin prescription in south Sweden.
治疗传统、患者社会经济特征与医生早期新药处方——瑞典南部瑞舒伐他汀处方的多层次分析
Eur J Clin Pharmacol. 2009 Feb;65(2):141-50. doi: 10.1007/s00228-008-0569-4. Epub 2008 Oct 4.
4
Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. The Skaraborg Hypertension and Diabetes Project.心血管疾病高风险女性的胆固醇治疗效果不如相应的男性。斯卡罗堡高血压与糖尿病项目。
Eur J Clin Pharmacol. 2008 Aug;64(8):815-20. doi: 10.1007/s00228-008-0482-x. Epub 2008 Apr 4.
5
Developments in post-marketing comparative effectiveness research.上市后比较效果研究的进展
Clin Pharmacol Ther. 2007 Aug;82(2):143-56. doi: 10.1038/sj.clpt.6100249. Epub 2007 Jun 6.
6
Understanding the effects of a decentralized budget on physicians' compliance with guidelines for statin prescription--a multilevel methodological approach.理解分散预算对医生遵循他汀类药物处方指南的影响——一种多层次方法学途径。
BMC Health Serv Res. 2007 May 8;7:68. doi: 10.1186/1472-6963-7-68.
7
Neighbourhood effects and the real world beyond randomized community trials: a reply to Michael J Oakes.邻里效应与随机社区试验之外的现实世界:对迈克尔·J·奥克斯的回应
Int J Epidemiol. 2006 Oct;35(5):1361-3. doi: 10.1093/ije/dyl211. Epub 2006 Sep 28.
8
Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors.治疗决策模型中的解释变异在患者、医生和诊所因素之间进行划分。
J Clin Epidemiol. 2006 Jan;59(1):18-25. doi: 10.1016/j.jclinepi.2005.07.005. Epub 2005 Nov 7.
9
A brief conceptual tutorial on multilevel analysis in social epidemiology: interpreting neighbourhood differences and the effect of neighbourhood characteristics on individual health.社会流行病学中多层次分析的简要概念教程:解读邻里差异以及邻里特征对个体健康的影响。
J Epidemiol Community Health. 2005 Dec;59(12):1022-8. doi: 10.1136/jech.2004.028035.
10
Understanding adherence to official guidelines on statin prescribing in primary health care--a multi-level methodological approach.了解初级卫生保健中他汀类药物处方遵循官方指南的情况——一种多层次的方法。
Eur J Clin Pharmacol. 2005 Oct;61(9):657-65. doi: 10.1007/s00228-005-0975-9. Epub 2005 Oct 19.